Actonel DR, a new delayed-release form of risedronate (Actonel), for postmenopausal osteoporosis
November 2011
You'll see Actonel DR, a new delayed-release form of risedronate (Actonel), for postmenopausal osteoporosis.
Actonel DR will be promoted as more convenient because it's taken WITH breakfast...instead of 30 to 60 minutes BEFORE breakfast like the other oral bisphosphonates.
Actonel DR is enteric-coated to keep the tablet from dissolving in the stomach...plus it contains EDTA to help bind small amounts of calcium, magnesium, or other cations from food.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive